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Clinics and pathology 
Disease 
B cell progenitor acute lymphoid leukemia (B-ALL) 
Epidemiology 
Only one case to date, a 22-year-old male patient 
(Hidalgo-Curtis et al., 2008). 
Prognosis 
Complete remission was obtained, a relapse occured. 




The translocation was found solely in the main clone, 
and a subclone also showed a +21. 





DNA- and RNA binding protein; pre-mRNA splicing 
factor; binds specifically to intronic polypyrimidine 
tracts. 
Role in transcription and RNA splicing: SFPQ, often 
called PSF, is a coactivator of Fox proteins, which bind 
the RNA element UGCAUG and regulate alternative 
pre-mRNA splicing. SFPQ and NONO are part of a 
large complex with all the snRNPs. SFPQ is 
phosphorylated by GSK3, which prevents SFPQ from 
binding PTPRC (CD45 antigen) pre-mRNA. The  
association of HNRNPL and SFPQ drives the change in 
PTPRC (CD45) splicing (CD45 undergoes alternative 
splicing in response to T-cell activation). 
DNA damage: DNA double-strand breaks are repaired 
via nonhomologous DNA end joining and homologous 
recombination. The SFPQ/NONO heterodimer 
enhances DNA strand break rejoining. SFPQ has 
homologous recombination and non-homologous end 
joining activities. SFPQ is associated with the RAD51 
protein complex. 
Role in transcriptional regulation: SFPQ and PTK6 
(protein tyrosine kinase 6, also called BRK) play a role 
downstream of the EGF receptor (EGFR). SFPQ and 
NONO form complexes with the androgen receptor 






ABL1, when localized in the nucleus, induces 
apoptosis after DNA damage. Cytoplasmic ABL1 has a 
possible function in adhesion signalling (Turhan, 
2008). 




Break in the 3' of SFPQ exon 10 and reunion with 
ABL1 intron 3; a further mRNA splicing gives rise to a 
chimeric SFPQ exons 1 to 9 (nucleotide 2072) fused to 
ABL1 exon 4 to end. 






Atlas Genet Cytogenet Oncol Haematol. 2010; 14(10)   975 
Fusion protein 
Description 
1609 amino acids fusion protein of 174 kDa; retains 
most of SFPQ, including the RNA recognition motifs 
and the coiled-coil domain (dimerization domain), 
fused to the SH2 domain of ABL1; the fusion protein 
also includes the SH1 domain (tyrosine kinase activity), 
the nuclear localization domain, and the actin binding 
domain of ABL1. 
Oncogenesis 
Constitutive tyrosine kinase activation is likely, 
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